Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma

Annals of Neurology

Volumn 40, Issue 5, 1996, Pages 739-749

  Meriney, Stephen D ^a   Hulsizer, Susan C ^b   Lennon, Vanda A ^c   Grinnell, Alan D ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM; CONOTOXIN; IMMUNOGLOBULIN G; NITRENDIPINE;

ACTION POTENTIAL; ARTICLE; CALCIUM CURRENT; CELL ADHESION; CELL CYCLE; EATON LAMBERT SYNDROME; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INCUBATION TIME; LUNG SMALL CELL CANCER; MYASTHENIA; NEUROMUSCULAR SYNAPSE; PATCH CLAMP; PRIORITY JOURNAL;

EID: 0029811225     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400510     Document Type: Article

References (64)

1. Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasm. Am J Physiol 1956;187:612-613
2. O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain 1988; 111:577-596
3. Elmqvist D, Lambert EH. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 1968;43:689-713
4. Vincent A, Lang B, Newsom-Davis J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989;12:496-502
5. Fukunaga H, Engel A, Osame M, Lambert H. Paucity and disorganization of presynaptic active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982;5:686-697
6. Fukunaga H, Engel A, Lang B, et al. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic active zones. Proc Natl Acad Sci USA 1983;80:7636-7640
7. Lang B, Molenaar PC, Newsome-Davis J, Vincent A. Passive transfer of Lambert-Eaton myasthenic syndrome in mice: decreased rates of resting and evoked release of acetylcholine from skeletal muscle. J Neurochem 1984;42:658-662
8. Kim YI. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma. Muscle Nerve 1985;8:162-172
9. Lambert EH, Lennon VA. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities. Muscle Nerve 1988;11: 1133-1145
10. Smith DO, Conklin MW, Jensen PJ, Atchison WD. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J Physiol 1995;487:115-123
11. De Aizpurua HJ, Lambert EH, Griesmann GE, et al. Antagonisms of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies ω-conotoxin and adenosine. Cancer Res 1988;48:4719-4724
12. Nagel A, Engel AG, Lang B, et al. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann Neurol 1988;24: 552-558
13. Peers C, Johnston I, Lang B, Wray D. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction. Neurosci Lett 1993;153:45-48
14. Kim YI, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 1988;239:405-408
15. Cunningham JM, Lennon VA, Lambert EH, Scheithauer B. Acetylcholine receptors in small cell carcinomas. J Neurochem 1985;45:159-167
16. Williams CL, Lennon VA. Activation of M3 muscarinic acetylcholine receptors inhibits voltage-dependent calcium influx in small cell lung carcinoma. J Biol Chem 1990;265:1443-1447
17. Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc 1991;66:1209-1216
18. Oguro-Okano M, Griesmann GE, Wieben ED, et al. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 1992;67:1150-1159
19. Pancrazio JJ, Viglione MP, Tabbara IA, Kim YI. Voltage-dependent ion channels in small-cell lung cancer cells. Cancer Res 1989;49:5901-5906
20. Johansson S, Rydqvist B, Swerup C, et al. Action potentials of cultured human oat cells: whole-cell measurements with patch-clamp technique. Acta Physiol Scand 1989;135:573-578
21. Viglione MP, Blandino JK, Kim SJ, Kim YI. Effects of Lambert-Eaton syndrome serum and IgG on calcium and sodium currents in small-cell lung cancer cells. Ann NY Acad Sci 1993; 681:418-421
22. McCann FV, Pettengill OS, Cole JJ, et al. Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung. Science 1981;212:1155-1157
23. 2+ flux in a human small cell carcinoma line. Nature 1985;317:737-739
24. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-ω-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504
25. Sher E, Padiella A, Clementi F. Voltage-operated calcium channels in small cell lung carcinoma cell lines: pharmacological, functional and immunological properties. Cancer Res 1990;50:3892-3896
26. Pancrazio JJ, Oie HK, Kim YI. Voltage-sensitive calcium channels in a human small cell cancer cell line. Acta Physiol Scand 1992;144:463-468
27. Codignola A, Tarroni P, Clementi F, et al. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. J Biol Chem 1993;268:26240-26247
28. Lennon VA, Kryzer T, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474
29. Moody TW, Russell EK, O'Donohue TL, et al. Bombesin-like peptides in small cell lung cancer: biochemical characterization and secretion from a cell line. Life Sci 1983;32:487-493
30. Randall AD, Tsien RW. Pharmacological dissection of multiple types of calcium channel currents in rat cerebellar granule neurons. J Neurosci 1995;15:2995-3012
31. Llinas R, Sugimori M, Hillman DE, Cherksey B. Distribution and functional significance of the P-type, voltage-dependent calcium channels in the mammalian central nervous system. Trends Neurosci 1992;9:351-355
32. Mintz IM, Adams ME, Bean BP. P-Type calcium channels in rat central and peripheral neurons. Neuron 1992;9:85-95
33. 2+ channels. Neuron 1992;9:69-77
34. Hulsizer SC, Meriney SD, Grinnell AD, Lennon VA. N- and L-like calcium currents in lung cancer cells are blocked by Lambert-Eaton IgG. Soc Neurosci Abstr 1991;17:1159
35. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100
36. Wagner JA, Snowman AM, Biswas A, et al. ω-Conotoxin GVIA binding to a high affinity receptor in brain: characterization, calcium sensitivity, and solubilization. J Neurosci 1988; 8:3354-3359
37. Ohmori H, Yoshii M. Surface potential reflected in both gating and permeation mechanisms of sodium and calcium channels of the tunicate egg cell membrane. J Physiol 1977;267:429-463
38. Mintz IM, Venema VJ, Swiderek, et al. P-Type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature 1992;355: 827-829
39. Williams CL, Lennon VA. Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. Mol Biol Cell 1991;2:373-382
40. 2+ channels expressed in small cell lung carcinomas of patients with and without Lambert-Eaton myasthenic syndrome (LES). Soc Neurosci Abstr 1993;19:1755
41. Barry ELR, Viglione MP, Kim YI, Froehner SC. Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells. J Neurosci 1995;15:274-283
42. Viglione MP, O'Shaughnessy TJ, Kim YI. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells, J Physiol 1995;488:303-317
43. Tsien RW, Lipscombe D, Madison DV, et al. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 1988;10:431-438
44. Bossu JL, De Waard M, Feltz A. Two types of calcium channels are expressed in adult bovine chromaffin cells. J Physiol 1991;437:621-634
45. Reeve HL, Vaughan PF, Peers C. Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: actions and possible interactions of dihydropyridines and omega conotoxin. Eur J Neurosci 1994;6:943-952
46. Usowicz MM, Sugimori M, Cherksey B, Llinas R. P-Type calcium channels in the somata and dendrites of adult cerebellar Purkinje cells. Neuron 1992;9:1185-1199
47. Passafaro M, Clementi F, Sher E. Metabolism of omega-conotoxin-sensitive voltage-operated calcium channels in human neuroblastoma cells: modulation by cell differentiation and anti-channel antibodies. J Neurosci 1992;12:3372-3379
48. Uchitel OD, Protti DA, Sanchez V, et al. P-Type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 1992;89:3330-3333
49. 2+ currents blocked by the spider toxin omega-Aga-IVA. Neuroreport 1993;5:333-336
50. Protti DA, Sanchez VA, Cherksey BD, et al. Mammalian neuromuscular transmission blocked by funnel web toxin. Ann NY Acad Sci 1993;681:405-407
51. Viglione MP, Creutz CE, Kim YI. Lambert-Eaton syndrome: antigen-antibody interaction and calcium current inhibition in chromaffin cells. Muscle Nerve 1992;15:1325-1333
52. Lennon VA, Lambert EH, Whittingham S, Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle-Nerve 1982;5:S21-S25
53. Hewett SJ, Atchison WD. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels. Brain Res 1992;599:324-332
54. Peers C, Lang B, Newsom-Davis J, Wray D. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma X glioma cell line. J Physiol 1990;421: 293-308
55. Lang B, Newsome-Davis J, Wray D. The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle. Proc R Soc Lond B Biol Sci 1988; 235:103-110
56. 2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs. Neurosci Lett 1994;181:50-56
57. Verschuuren JJ, Lang B, Newsom-Davis J, et al. Antibodies to the beta-subunit of the voltage-gated calcium channel in patients with the Lambert-Eaton myasthenic syndrome. Neurology 1996;46:A128
58. Tunkel R, Rosenfeld MR, Dalmau J, et al. Animals immunized with MysB, a Lambert-Eaton myasthenic syndrome antigen, develop high titer antibodies but no evidence of disease. Neurology 1996;46:A129
59. Johnston I, Lang B, Leys K, Newsom-Davis J. Heterogeneity of calcium channel autoantibodies detected using a small cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient. Neurology 1994;44:334-338
60. 2+ channels. Neuron 1994;12:317-326
61. Leveque C, Hoshino T, David P, et al. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc Natl Acad Sci USA 1992;89:3625-3629
62. Szabo A, Dalmau J, Manley G, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991;67:325-333
63. Buckanovitch RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing nervous system. Neuron 1993;11:657-672
64. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994;44:2236-2240, 2412-2415